Join Growin Stock Community!
Beta
Back to CVS.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
cash-and-debt-chart

CVS Cash & Debt

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

As of Q1'26, CVS's cash and short-term investments stood at $9.5B USD, reflecting a decline from the previous quarter's $10.7B USD, while total debt decreased to $78.3B USD from $80.0B USD in Q4'25, resulting in a net debt position of approximately $68.8B USD. Over the period from Q2'23 to Q1'26, cash and short-term investments exhibited volatility, peaking at $16.9B USD in Q2'23 and $16.3B USD in Q2'24 before trending downward to a low of $9.5B USD, with notable drops in Q4'23 ($11.5B USD) and Q3'24 ($9.7B USD). In contrast, debt remained relatively stable around $80B-$83B USD through Q2'24, then gradually declined by about 5% to $78.3B USD by Q1'26, indicating improved leverage but persistent pressure on liquidity amid fluctuating cash reserves. This bar chart highlights CVS's ongoing efforts to manage debt amid inconsistent cash flows, with no dominant inflection points beyond seasonal quarterly variations.